The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene

NCT04360057 | Completed

• 1 other identifier: HSC20160369H
• Study Type: interventional
• Target: 63
• Locations: 1 country
• Sites: 1

Brief Summary

This exploratory cross sectional cohort study will evaluate the feasibility and fidelity of using an innovative strategy, the Patient Motivational Dialogue (PMD)/PMDPlus that will intentionally motivate and encourage the patient toward self-advocacy for their Health Care Professional's (HCP's) hand hygeine (HH) adherence.

Conditions

Hand Disinfection

Keywords

Motivation, hand hygiene

Outcome Measures

Primary Outcomes (1)

• The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene

  At the last clinic visit, the PI or research assistant will ask the patient this nominal question: "Have you ever ask your physician or your HCP to clean their hands during your visits here?" If yes, describe the circumstances. If no, describe why not. Verbal responses will be recorded.

  At treatment completion, an average of 4-6 months

Study Arms (1)

Hand Hygiene education

OTHER

Other: PMD; Other: PMDPlus

Interventions

PMD OTHER

A script used to train the physician to engage with the patient in the topic of hand hygiene compliance used on the initial visit.

Also known as: Patient Motivational Dialogue

Hand Hygiene education

PMDPlus OTHER

A script used to train the physician to engage with the patient in the topic of hand hygiene compliance on follow up visits

Also known as: Patient Motivational Dialogue Plus

Hand Hygiene education

Eligibility Criteria

• Age: 3 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• English or Spanish speaking
• Able to understand instructions given by physician
• Receiving care in radiation oncology clinic and/or chemotherapy clinic at Cancer Therapy Research Center at University of Texas Health Science Center (UTHSCSA)

You may not qualify if:

• Unable to understand instructions given by physician

Sponsors & Collaborators

• The University of Texas Health Science Center at San Antonio: lead

Study Sites (1)

Cancer Therapy & Research Center at UTHSCSA

San Antonio, Texas, 78229, United States

Location

Study Officials

• Patti G Grota

  University of Texas Health at San Antonio

  PRINCIPAL INVESTIGATOR

• Tony Eng, MD

  University of Texas Health at San Antonio

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Subjects will be included from two oncology clinics, one in radiation oncology and one in chemotherapy oncology

Study Record Dates

• First Submitted: April 14, 2020
• First Posted: April 24, 2020
• Study Start: October 1, 2016
• Primary Completion: May 30, 2017
• Study Completion: March 13, 2018
• Last Updated: April 24, 2020

Record last verified: 2020-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)